FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1480949757> ?p ?o ?g. }

• W1480949757 abstract "Abstract Background Fatal heroin overdose is a significant cause of mortality for injection drug users (IDUs). Many of these deaths are preventable because opiate overdoses can be quickly and safely reversed through the injection of Naloxone [brand name Narcan], a prescription drug used to revive persons who have overdosed on heroin or other opioids. Currently, in several cities in the United States, drug users are being trained in naloxone administration and given naloxone for immediate and successful reversals of opiate overdoses. There has been very little formal description of the challenges faced in the development and implementation of large-scale IDU naloxone administration training and distribution programs and the lessons learned during this process. Methods During a one year period, over 1,000 participants were trained in SKOOP (Skills and Knowledge on Opiate Prevention) and received a prescription for naloxone by a medical doctor on site at a syringe exchange program (SEP) in New York City. Participants in SKOOP were over the age of 18, current participants of SEPs, and current or former drug users. We present details about program design and lessons learned during the development and implementation of SKOOP. Lessons learned described in the manuscript are collectively articulated by the evaluators and implementers of the project. Results There were six primary challenges and lessons learned in developing, implementing, and evaluating SKOOP. These include a) political climate surrounding naloxone distribution; b) extant prescription drug laws; c) initial low levels of recruitment into the program; d) development of participant appropriate training methodology; e) challenges in the design of a suitable formal evaluation; and f) evolution of program response to naloxone. Conclusion Other naloxone distribution programs may anticipate similar challenges to SKOOP and we identify mechanisms to address them. Strategies include being flexible in program planning and implementation, developing evaluation instruments for feasibility and simplicity, and responding to and incorporating feedback from participants." @default.
• W1480949757 created "2016-06-24" @default.
• W1480949757 creator A5024092681 @default.
• W1480949757 creator A5053420728 @default.
• W1480949757 creator A5057264401 @default.
• W1480949757 creator A5059680113 @default.
• W1480949757 creator A5065825255 @default.
• W1480949757 creator A5081159656 @default.
• W1480949757 creator A5090309497 @default.
• W1480949757 date "2007-01-25" @default.
• W1480949757 modified "2023-10-06" @default.
• W1480949757 title "Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City" @default.
• W1480949757 cites W1966769583 @default.
• W1480949757 cites W1972712963 @default.
• W1480949757 cites W2007750751 @default.
• W1480949757 cites W2016931223 @default.
• W1480949757 cites W2021363900 @default.
• W1480949757 cites W2023896204 @default.
• W1480949757 cites W2032084541 @default.
• W1480949757 cites W2049502834 @default.
• W1480949757 cites W2057008548 @default.
• W1480949757 cites W2064047117 @default.
• W1480949757 cites W2084227946 @default.
• W1480949757 cites W2131952463 @default.
• W1480949757 cites W2161958405 @default.
• W1480949757 cites W2766224341 @default.
• W1480949757 cites W3122051711 @default.
• W1480949757 cites W4243507497 @default.
• W1480949757 doi "https://doi.org/10.1186/1477-7517-4-3" @default.
• W1480949757 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1797013" @default.
• W1480949757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17254345" @default.
• W1480949757 hasPublicationYear "2007" @default.
• W1480949757 type Work @default.
• W1480949757 sameAs 1480949757 @default.
• W1480949757 citedByCount "54" @default.
• W1480949757 countsByYear W14809497572012 @default.
• W1480949757 countsByYear W14809497572013 @default.
• W1480949757 countsByYear W14809497572014 @default.
• W1480949757 countsByYear W14809497572015 @default.
• W1480949757 countsByYear W14809497572017 @default.
• W1480949757 countsByYear W14809497572018 @default.
• W1480949757 countsByYear W14809497572019 @default.
• W1480949757 countsByYear W14809497572020 @default.
• W1480949757 countsByYear W14809497572021 @default.
• W1480949757 countsByYear W14809497572022 @default.
• W1480949757 countsByYear W14809497572023 @default.
• W1480949757 crossrefType "journal-article" @default.
• W1480949757 hasAuthorship W1480949757A5024092681 @default.
• W1480949757 hasAuthorship W1480949757A5053420728 @default.
• W1480949757 hasAuthorship W1480949757A5057264401 @default.
• W1480949757 hasAuthorship W1480949757A5059680113 @default.
• W1480949757 hasAuthorship W1480949757A5065825255 @default.
• W1480949757 hasAuthorship W1480949757A5081159656 @default.
• W1480949757 hasAuthorship W1480949757A5090309497 @default.
• W1480949757 hasBestOaLocation W14809497571 @default.
• W1480949757 hasConcept C118552586 @default.
• W1480949757 hasConcept C126322002 @default.
• W1480949757 hasConcept C138816342 @default.
• W1480949757 hasConcept C155164915 @default.
• W1480949757 hasConcept C15744967 @default.
• W1480949757 hasConcept C159110408 @default.
• W1480949757 hasConcept C170493617 @default.
• W1480949757 hasConcept C2426938 @default.
• W1480949757 hasConcept C2776315796 @default.
• W1480949757 hasConcept C2778140631 @default.
• W1480949757 hasConcept C2778750930 @default.
• W1480949757 hasConcept C2778903686 @default.
• W1480949757 hasConcept C2779148768 @default.
• W1480949757 hasConcept C2780035454 @default.
• W1480949757 hasConcept C2781063702 @default.
• W1480949757 hasConcept C3017944768 @default.
• W1480949757 hasConcept C545542383 @default.
• W1480949757 hasConcept C71924100 @default.
• W1480949757 hasConcept C98274493 @default.
• W1480949757 hasConceptScore W1480949757C118552586 @default.
• W1480949757 hasConceptScore W1480949757C126322002 @default.
• W1480949757 hasConceptScore W1480949757C138816342 @default.
• W1480949757 hasConceptScore W1480949757C155164915 @default.
• W1480949757 hasConceptScore W1480949757C15744967 @default.
• W1480949757 hasConceptScore W1480949757C159110408 @default.
• W1480949757 hasConceptScore W1480949757C170493617 @default.
• W1480949757 hasConceptScore W1480949757C2426938 @default.
• W1480949757 hasConceptScore W1480949757C2776315796 @default.
• W1480949757 hasConceptScore W1480949757C2778140631 @default.
• W1480949757 hasConceptScore W1480949757C2778750930 @default.
• W1480949757 hasConceptScore W1480949757C2778903686 @default.
• W1480949757 hasConceptScore W1480949757C2779148768 @default.
• W1480949757 hasConceptScore W1480949757C2780035454 @default.
• W1480949757 hasConceptScore W1480949757C2781063702 @default.
• W1480949757 hasConceptScore W1480949757C3017944768 @default.
• W1480949757 hasConceptScore W1480949757C545542383 @default.
• W1480949757 hasConceptScore W1480949757C71924100 @default.
• W1480949757 hasConceptScore W1480949757C98274493 @default.
• W1480949757 hasIssue "1" @default.
• W1480949757 hasLocation W14809497571 @default.
• W1480949757 hasLocation W14809497572 @default.
• W1480949757 hasLocation W14809497573 @default.
• W1480949757 hasLocation W14809497574 @default.
• W1480949757 hasLocation W14809497575 @default.
• W1480949757 hasLocation W14809497576 @default.

• next